The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Learn effective ways to make quick cash for emergency expenses. Be ready for financial surprises with these practical tips.
22,319 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Circle has delivered a dramatic swing in 2024. This article breaks down the main reason it could keep climbing, the r...
Harvey, an AI-driven legal tech startup, has surged to an $11 billion valuation after attracting OpenAI backing. The ...
As primary races heat up in May 2026, some campaign staffers tell they are betting on outcomes using private predicti...
DeFi endured its worst April in over a year, with hundreds of millions lost to hacks. The sector now faces a shift to...
A landmark analysis of Swedish twins suggests genetics may influence about 45% of how people invest, from trading fre...
Ken Griffin, the Citadel founder once openly skeptical of AI, has pivoted to embracing its potential, telling audienc...
Bitwise argues that investors have not fully priced Hyperliquid's expansion into a multi-asset platform and the value...
PepsiCo’s chief people officer says the company wins by hiring people who hustle, stay curious, and adapt quickly in ...
Visa now dominates crypto-card payments, handling the vast majority of activity as stablecoins aimed to bypass legacy...
Polkadot has traveled a roller coaster ride from a multi-dollar high to price pressures and shifting crypto cycles. T...
Nvidia CEO Jensen Huang reiterates a generous pay policy as AI-driven profits soar, highlighting how wealth from tech...